Rayner has received European CE Mark for its first hydrophobic fully preloaded IOL injection system. The RayOne Hydrophobic IOL is made of a new proprietary material that is glistening-free, with a patented “Cornerstone” lens shape for stability during lens delivery and post-implantation. The new 6 mm aspheric IOL comes preloaded inside Rayner’s RayOne injector with a 1.65 mm nozzle tip diameter for sub-2.2 mm micro-incision cataract surgery.
RayOne Hydrophobic is designed to overcome the compromises that current hydrophobic IOLs present, by providing surgeons with an easy-to-use solution in the operating room as well as the visual outcomes that cataract patients demand.
“Since the launch of our hydrophilic RayOne preloaded IOL in 2016, surgeons have told us that they would love to see our highly intuitive delivery system offered with a hydrophobic lens,” Tim Clover, Rayner CEO, said in a company news release. “We are excited to deliver on this request with our new RayOne Hydrophobic which overcomes the clinical and practical challenges faced by operating room staff on a daily basis.”
- Ultra glistening-free – independently tested at the world-renowned University Hospital Heidelberg to be glistening-free with ‘absolute equivalent or superior performance’ to the best hydrophobic IOLs currently available on the market.
- Ultra stable – patented Cornerstone lens shape balances the naturally stiffer hydrophobic material as it travels down the injector for predictable and repeatable implantation. Rayner’s anti-vaulting haptics then lock against the unique Cornerstone tabs for superb stability in the eye.
- Ultra smooth – Lock & Roll technology rolls the lens to half its size for a single smooth injection through a sub-2.2 mm incision. The RayOne Hydrophobic IOL then unrolls naturally for more efficient surgery time, irrespective of the temperature within the operating room.
“The easy-to-use injector system delivers the lens without drama. The RayOne Hydrophobic IOL provided consistent, excellent refractive outcomes,” said Kevin Waltz, MD, Chief Medical Officer of Central American Eye Clinics, who led the clinical evaluation for RayOne Hydrophobic. “There was no VA variance over the first 3 months after implantation. All lenses were stable and well-centered, with no IOL-related adverse events with 50 lenses implanted.”
RayOne Hydrophobic utilizes the same true two-step fully preloaded injector as the rest of the RayOne family of IOLs (spheric, aspheric, toric, trifocal).
“When developing RayOne, our vision was a single and intuitive platform with an IOL for every patient need,” Warwick Strand, Rayner Marketing Director, said in the news release. “With the introduction of RayOne Hydrophobic, we now offer surgeons a choice of IOL material in addition to a selection of advanced optic technologies.”
RayOne Hydrophobic is available in one size across a full power range (-10 to +32D) so that only one monofocal IOL is required for all patients.
RayOne Hydrophobic is now available to CE Mark-accepting countries.